How we manage AB plasma inventory in the blood center and transfusion service

Transfusion

Volumn 53, Issue 8, 2013, Pages 1627-1633

  Yazer, Mark ^a   Eder, Anne F ^a   Land, Kevin J ^b  

^a not available ^*

^b not available   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTHROMBIN COMPLEX;

ARTICLE; BLOOD BANK; BLOOD COMPONENT; BLOOD DONOR; BLOOD GROUP AB; BLOOD GROUP TYPING; BLOOD TRANSFUSION; COMPLIANCE (PHYSICAL); COMPUTERIZED PROVIDER ORDER ENTRY; ELECTIVE SURGERY; HEALTH CARE QUALITY; HOSPITAL POLICY; HUMAN; INTERPERSONAL COMMUNICATION; NURSING PROTOCOL; PATIENT IDENTIFICATION; PLASMA; PLASMA TRANSFUSION; PRACTICE GUIDELINE; TRANSFUSION RELATED ACUTE LUNG INJURY; TURNAROUND TIME; UNITED STATES;

EID: 84882452354     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12223     Document Type: Article

References (28)

1. US Department of Health and Human Services. The 2009 national blood collection and utilization survey report. Washington, DC: DHHS, 2011.
2. Daniels G,. Human blood groups. 2nd ed. Oxford: Blackwell Science Ltd; 2002.
3. Borgman MA, Spinella PC, Perkins JG, Grathwohl KW, Repine T, Beekley AC, Sebesta J, Jenkins D, Wade CE, Holcomb JB,. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007; 63: 805-813.
4. American Association of Blood Banks. Association Bulletin #12-02 TRALI Mitigation Update. September 2012.
5. Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion. Annual summary for fiscal year 2011. 2013. [cited 2013 Apr 11]. Available from: URL: http://www.fda.gov/BiologicsBloodVaccines/ SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm346639.htm.
6. Chapman CE, Stainsby D, Jones H, Love E, Massey E, Win N, Navarrete C, Lucas G, Soni N, Morgan C, Choo L, Cohen H, Williamson LM,. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009; 49: 440-452.
7. Eder AF, Dy BA, Perez JM, Rambaud M, Benjamin RJ,. The residual risk of transfusion-related acute lung injury at the American Red Cross (2008-2011): limitations of a predominantly male-donor plasma mitigation strategy. Transfusion 2013. doi: 10.1111/j.1537-2995.2012.03935.x.
8. Tanaka KA, Szlam F,. Treatment of massive bleeding with prothrombin complex concentrate: argument for. J Thromb Haemost 2010; 8: 2589-2591.
9. Silliman CC, Moore EE, Le T, Land KJ,. One to one to what? Transfusion 2010; 50: 2066-2067.
10. McWilliams B, Yazer MH, Cramer J, Triulzi DJ, Waters JH,. Incomplete pretransfusion testing leads to surgical delays. Transfusion 2012; 52: 2139-2144.
11. Goodnough LT, Viele M, Fontaine MJ, Jurado C, Stone N, Quach P, Chua L, Chin ML, Scott R, Tokareva I, Tabb K, Sharek PJ,. Implementation of a two-specimen requirement for verification of ABO/Rh for blood transfusion. Transfusion 2009; 49: 1321-1328.
12. Baer VL, Henry E, Lambert DK, Stoddard RA, Wiedmeier SE, Eggert LD, Ilstrup S, Christensen RD,. Implementing a program to improve compliance with neonatal intensive care unit transfusion guidelines was accompanied by a reduction in transfusion rate: a pre-post analysis within a multihospital health care system. Transfusion 2011; 51: 264-269.
13. Tavares M, Diquattro P, Nolette N, Conti G, Sweeney J,. Reduction in plasma transfusion after enforcement of transfusion guidelines (CME). Transfusion 2011; 51: 754-761.
14. Sarode R, Refaai MA, Matevosyan K, Burner JD, Hampton S, Rutherford C,. Prospective monitoring of plasma and platelet transfusions in a large teaching hospital results in significant cost reduction. Transfusion 2010; 50: 487-492.
15. Stanworth SJ, Grant-Casey J, Lowe D, Laffan M, New H, Murphy MF, Allard S,. The use of fresh-frozen plasma in England: high levels of inappropriate use in adults and children. Transfusion 2011; 51: 62-70.
16. Yang L, Stanworth S, Hopewell S, Doree C, Murphy M,. Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials. Transfusion 2012; 52: 1673-1686.
17. Stanworth SJ, Walsh TS, Prescott RJ, Lee RJ, Watson DM, Wyncoll D,. A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time. Crit Care 2011; 15: R108.
18. Roback JD, Caldwell S, Carson J, Davenport R, Drew MJ, Eder A, Fung M, Hamilton M, Hess JR, Luban N, Perkins JG, Sachais BS, Shander A, Silverman T, Snyder E, Tormey C, Waters J, Djulbegovic B,. Evidence-based practice guidelines for plasma transfusion. Transfusion 2010; 50: 1227-1239.
19. Haspel RL, Uhl L,. How do I audit hospital blood product utilization? Transfusion 2012; 52: 227-230.
20. Yazer MH, Waters JH,. How do I implement a hospital-based blood management program? Transfusion 2012; 52: 1640-1645.
21. Isaak EJ, Tchorz KM, Lang N, Kalal L, Slapak C, Khalife G, Smith D, McCarthy MC,. Challenging dogma: group A donors as "universal plasma" donors in massive transfusion protocols. Immunohematology 2011; 27: 61-65.
22. Zielinski MD, Johnson PM, Jenkins D, Goussous N, Stubbs JR,. Emergency use of prethawed Group A plasma in trauma patients. J Trauma Acute Care Surg 2013; 74: 69-74, discussion 74-5.
23. Shanwell A, Andersson TM, Rostgaard K, Edgren G, Hjalgrim H, Norda R, Melbye M, Nyren O, Reilly M,. Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma. Vox Sang 2009; 96: 316-323.
24. Inaba K, Branco BC, Rhee P, Holcomb JB, Blackbourne LH, Shulman I, Nelson J, Demetriades D,. Impact of ABO-identical vs ABO-compatible nonidentical plasma transfusion in trauma patients. Arch Surg 2010; 145: 899-906.
25. Callum JL, Nascimento B, Tien H, Rizoli S,. Editorial: "formula-driven" versus "lab-driven" massive transfusion protocols: at a state of clinical equipoise. Transfus Med Rev 2009; 23: 247-254.
26. Riskin DJ, Tsai TC, Riskin L, Hernandez-Boussard T, Purtill M, Maggio PM, Spain DA, Brundage SI,. Massive transfusion protocols: the role of aggressive resuscitation versus product ratio in mortality reduction. J Am Coll Surg 2009; 209: 198-205.
27. Nunez TC, Young PP, Holcomb JB, Cotton BA,. Creation, implementation, and maturation of a massive transfusion protocol for the exsanguinating trauma patient. J Trauma 2010; 68: 1498-1505.
28. Callum JL, Rizoli S,. Assessment and management of massive bleeding: coagulation assessment, pharmacologic strategies, and transfusion management. Hematology Am Soc Hematol Educ Program 2012; 2012: 522-528.